Quick Links

 Molecular Biology

Molecular BiologyCity of Hope’s Department of Molecular Biology, originally Molecular Genetics, was formed in 1982 under the direction of Keiichi Itakura, Ph.D., professor of molecular biology. Research interests in the department include an array of biological systems and problems, but the unifying theme is mechanisms regulating expression of genetic information at both the transcriptional level (where DNA directs the synthesis of RNA) and the post-transcriptional level (meaning how genes control protein synthesis from newly-transcribed RNAs).

The department includes eight independent laboratories as well as the DNA/RNA Peptide Synthesis core facility, overseen by Bruce Kaplan, Ph.D. and the Electron Microscopy core facility, overseen by Marcia Miller, Ph.D. Other activities of the Department of Molecular Biology involve a state-of-the-art facility for peptide synthesis and modified RNA-DNA oligonucleotide synthesis.

Investigators within the department actively collaborate with investigators in the medical center, making important contributions to clinical investigations at City of Hope. The faculty also collaborates with the wider academic and scientific community. Faculty members have served numerous leadership roles, including with the National Institutes of Health, American Cancer Society and the Army Breast Cancer Research Program.

Department faculty members also teach and mentor graduate students in City of Hope’s Graduate School of Biological Sciences. The Department offers students the opportunity to carry out research in genetics, developmental biology, molecular genetics, molecular biochemistry, cell biology, molecular virology, and molecular and cellular immunology.
Laboratory Research

John J. Rossi, Ph.D. - siRNA and Ribozymes
The focus of this laboratory is the biology and therapeutic application of small RNAs, with particular emphasis on small interfering RNAs (siRNAs) and ribozymes as therapeutic agents for the treatment of HIV infection.

Adam Bailis, Ph.D. – Genetics and Molecular Biology
This laboratory investigates mechanisms of genome stability using yeast as a model system. They use a combination of genetic and molecular biological approaches to understand how homologous recombination is controlled to prevent deleterious genome rearrangements.

Rajesh Gaur, Ph.D. – Molecular Biology
Researchers in Dr. Gaur’s laboratory are interested in mechanisms regulating gene expression in a wide variety of disease states. Current research focuses on mechanisms regulating aberrant splicing of the CEACAM1 gene, which has potent tumor suppressor activity, as well as developing aptamers for the detection and targeting of breast cancer.

Keiichi Itakura, Ph.D. – Molecular Biology
Dr.Itakura's laboratory studies the role of ARID transcription factors in the development and maturation of adipocytes and carcinogenesis. They also study molecular events in energy balance, as well as the functions of homeobox genes in prostate cancer.

Ren-Jang Lin, Ph.D. – Molecular Biochemistry
This team studies pre-mRNA splicing mechanisms, focusing on spliceosomal helicases and in vivo splicing defects, and cancer-specific RNAs, particularly long, non-coding RNAs. Elucidating pre-mRNA splicing mechanisms may prove helpful in understanding a significant facet of cancer etiology.

Marcia Miller, Ph.D. – Molecular Immunogenetics
Oncogenic herpesvirus disproportionately causes tumors in immunocompromised patients.  This laboratory aims to understand how differences in key immune system genes may explain why some people develop these tumors while others do not.

Sergei N. Rodin, Ph.D.
- Theoretical Molecular Biology
Our research is focused on the reconstruction of major gene duplication events across the genome(s) in life history - from the origin of main adaptors of the genetic code (tRNAs and aminoacyl-tRNA synthetases) to the position-dependent neo-functionalisation of gene duplicates in higher organisms.

Piroska Szabo, Ph.D. – Epigenetics
This laboratory investigates the epigenetic mechanisms governing genomic imprinting using methods of genetics, biochemistry and molecular biology. The group is also involved in environmental reproductive epigenetics.

John Termini, Ph.D. – Molecular Biology
Members Dr. Termini's laboratory are interested in understanding the role of DNA damage in cancer.  This encompasses mechanisms of formation, structure and quantitative determination, functional implications and removal/repair. One particular example of DNA damage we are investigating is how free-radical mediated DNA damage caused by peroxidation of specific dietary polyunsaturated fatty acids may lead to precancerous mutations and chromosomal rearrangements.

 Search

Go!
Advanced Search Options
News & Publications Search

 Beckman Research Institute

Beckman Research InstituteRecognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.

 Support Our Research

With your help, City of Hope researchers pursue new clinical and laboratory findings, support promising young scientists, and acquire new laboratory technology.

Contact Donor Relations at 800-720-6824 for more information.

 Research Report

Research ReportProgram overviews and publications for City of Hope and Beckman research. (2004-2007 Report; 248-page indexed .pdf)
 
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S.News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.